MENU
LFSC
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

LFSC stock forecast, quote, news & analysis

The investment seeks long-term capital appreciation... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
LFSC
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for LFSC with price predictions
Oct 21, 2026

LFSC's RSI Oscillator ascending out of oversold territory

The RSI Indicator for LFSC moved out of oversold territory on October 19, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 7 similar instances when the indicator left oversold territory. In 7 of the 7 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 20 of 23 cases where LFSC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on LFSC as a result. In 29 of 32 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 90%.

The Moving Average Convergence Divergence (MACD) for LFSC just turned positive on October 21, 2026. Looking at past instances where LFSC's MACD turned positive, the stock continued to rise in 16 of 18 cases over the following month. The odds of a continued upward trend are 89%.

Following a +4.15% 3-day Advance, the price is estimated to grow further. Considering data from situations where LFSC advanced for three days, in 104 of 117 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.

LFSC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFSC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

The Aroon Indicator for LFSC entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Guardant Health (NASDAQ:GH), Nektar Therapeutics (NASDAQ:NKTR).

Industry description

The investment seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund (“ETF”) and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund’s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Market Cap

The average market capitalization across the F/M Emerald Life Sciences Innovation ETF (LFSC) ETF is 5.61B. The market cap for tickers in the group ranges from 136.8M to 24.17B. UTHR holds the highest valuation in this group at 24.17B. The lowest valued company is KRRO at 136.8M.

High and low price notable news

The average weekly price growth across all stocks in the F/M Emerald Life Sciences Innovation ETF (LFSC) ETF was 30%. For the same ETF, the average monthly price growth was 17%, and the average quarterly price growth was 392%. VRDN experienced the highest price growth at 25%, while TMDX experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the F/M Emerald Life Sciences Innovation ETF (LFSC) ETF was -9%. For the same stocks of the ETF, the average monthly volume growth was -8% and the average quarterly volume growth was -34%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 49
Price Growth Rating: 53
SMR Rating: 84
Profit Risk Rating: 80
Seasonality Score: 31 (-100 ... +100)
View a ticker or compare two or three
LFSC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
RBB Fund Inc (RBB)400 Bellevue Pkwy Ste 100Wilmington
Phone
N/A
Web
www.S1Fund.com.
LFSC's RSI Oscillator ascending out of oversold territory